You are here: Industry Insights > API

News List

Laurus Labs’ PAT touches Rs 110 crore in Q4 expresspharma
May 04, 2020
The consolidated revenue for the quarter was up by 32 per cent to Rs 839 crore as against Rs 635 crore in Q4 FY'19, a press release from the company said.
Wavelength Pharmaceuticals expands supplies of key drug ingredients for critically ill COVID-19 patients pharmaceutical-business-review
April 26, 2020
Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients (APIs), today reported that it has greatly expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients.
IICT, LAXAI LifeSciences collaborate for key pharma intermediates expresspharma
April 26, 2020
The collaboration will primarily focus on umifenovir, remdesivir and a key intermediate of hydroxychloroquine.
DCGI instructs SDCs to monitor supply and availability of paracetamol tablets, APIs expresspharma
April 24, 2020
Manufacturers of paracetamol tablets need to supply the minimum quantity but not less than their average supply of the past three months (January, February and March) in the domestic market.
Wavelength Ups API Production for Essential Respiratory Meds contractpharma
April 21, 2020
Products in demand due to coronavirus pandemic include Midazolam, Cisatracurium, and Rocuronium.
Lasa Supergenerics gets FDA nod for progesterone API expresspharma
April 14, 2020
Progesterone is one of the 26 drugs that had a restriction for exports due to COVID 19 pandemic as a result of India’s import dependency on Chinese suppliers.
American Regent Expands API Ops contractpharma
April 02, 2020
American Regent, a U.S. manufacturer of pharmaceuticals with manufacturing sites in New York and Ohio, will acquire Daiichi Sankyo Altkirch SARL.
Government asks MoEFCC to expedite clearance of API/intermediates expresspharma
March 31, 2020
The Union Government has asked the Ministry of Environment, Forest and Climate Change (MoEFCC) to expedite the prior environmental clearance to projects or activities in respect of APIs/bulk drugs and intermediates.
C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment C2 PHARMA
March 27, 2020
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin.
India to set up $1.3bn pharma manufacturing fund, says report europeanpharmaceuticalreview
March 26, 2020
Due to the COVID-19 outbreak, India has decided to invest $1.3 billion into its internal drug manufacturing capabilities, says a new report.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page